Investigation of α1-adrenoceptor subtypes mediating vasoconstriction in rabbit cutaneous resistance arteries

British Journal of Pharmacology

Volumn 122, Issue 5, 1997, Pages 825-832

  Smith, K M ^a   Macmillan, J B ^a   McGrath, J C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

1 adrenoceptor subtypes; Cutaneous resistance arteries

Indexed keywords

2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 5 METHYLURAPIDIL; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; ALPHA ETHYL 3,4,5 TRIMETHOXY ALPHA [3 [[2 (2 METHOXYPHENOXY)ETHYL]AMINO]PROPYL]BENZENEACETONITRILE FUMARATE; CHLOROETHYLCLONIDINE; COCAINE; CORTICOSTERONE; NORADRENALIN; PHENYLEPHRINE; PRAZOSIN; PROPRANOLOL; RECEPTOR SUBTYPE; ACETONITRILE DERIVATIVE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; DIOXANE DERIVATIVE; DRUG DERIVATIVE; IMIDAZOLE DERIVATIVE; N [5 (4,5 DIHYDRO 1H IMIDAZOL 2 YL) 5,6,7,8 TETRAHYDRO 2 HYDROXY 1 NAPHTHYL]METHANESULFONAMIDE; PIPERAZINE DERIVATIVE; TETRALIN DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR AFFINITY; RESISTANCE BLOOD VESSEL; SKIN BLOOD VESSEL; VASOCONSTRICTION; ANIMAL; ARTERY; DOSE RESPONSE; DRUG EFFECT; IN VITRO STUDY; METABOLISM; SKIN; VASCULAR RESISTANCE; VASCULARIZATION;

ACETONITRILES; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ARTERIES; CLONIDINE; DIOXANES; DOSE-RESPONSE RELATIONSHIP, DRUG; IMIDAZOLES; MALE; NOREPINEPHRINE; PHENYLEPHRINE; PIPERAZINES; PRAZOSIN; RABBITS; RECEPTORS, ADRENERGIC, ALPHA-1; SKIN; TETRAHYDRONAPHTHALENES; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 0030609134     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701451     Document Type: Article

References (44)

1. 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleens. Br. J. Pharmacol., 109, 80-87.
2. ALABASTER, V.A., KEIR, R.F. & PETERS, C.J. (1985). Comparison of activity of alpha-adrenoceptor agonists and antagonists in dog and rabbit isolated saphenous vein. Naunyn-Schmiedeberg's Arch. Pharmacol., 330, 33-36.
3. ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother., 14, 48-52.
4. 3H]-prazosin-labeled alpha-1 adrenergic receptors in rat brain and porcine neurointermediate lobe and tissue. J. Neurochem., 41, 538-542.
5. BYLUND, D.B. EIKENBERG, D.C., HIEBLE, P., LANGER, S.Z., LEFKOWITZ, R.J. MINNEMAN, K.P., MOLINOFF, P.B., RUFFOLLO, R.R. & TRENDELENBURG, U. (1994). IV. International Union of Pharmacology Nomenclature of Adrenoceptors. Am. Soc. Pharmacol. Exp. Ther., 46, 121-136.
6. DOCHERTY, J.R. & MCGRATH, J.C. (1980). A comparison of preand post-junctional potencies of several alpha-adrenoceptor agonists in the cardiovascular system and anococcygeus muscle of the rat. Naunyn-Schmiedeberg's Arch. Pharmacol., 312, 107-116.
7. DREW, M. (1985). What do antagonists tell us about α-adrenoceptors? Clin. Sci., 68, (suppl. 10). 15s-19s.
8. 1D-adrenoceptor subtype in rat myocardium, aorta and other tissues. Br. J. Pharmacol., 119, 269-276.
9. 1-Adrenoceptor subclassification in vascular smooth muscle. Trends Pharmacol. Sci., 7, 347-349.
10. 1C subtype. Mol. Pharmacol., 45, 703-708.
11. 1-adrenoceptors. Eur. J. Pharmacol., 272, R5-R6.
12. 2-adrenoceptor activation increases from the distal to the proximal part of the veins of canine limbs. Br. J. Pharmacol., 101, 387-393.
13. 2+ in smooth muscle. Nature, 329, 333-335.
14. 1-adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery. Br. J. Pharmacol., 113, 723-728.
15. 1-adrenoceptor subtypes in the rabbit prostate. J. Autonom. Pharmacol., 15, 271-278.
16. KENAKIN, T.P. (1982). The Schild regression in the process of receptor classification. Can. J. Physiol. Pharmacol., 60, 249-265.
17. 1D-adrenoceptor in the rat aorta. Br. J. Pharmacol., 114, 25P.
18. 1A receptor subtype. J. Pharmacol. Exp. Ther., 274, 97-103.
19. 1-adrenoceptor subtypes involved in adrenergic contractions of dog blood vessels. Br. J. Pharmacol, 112, 1167-1173.
20. 1-adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat. Br. J. Pharmacol., 120, 819-826.
21. LEECH, C.J. & FABER, J.E. (1996). Different α-adrenoceptor subtypes mediate constriction of arterioles and venules. Am. J. Physiol., 270, H710-H722.
22. MACMILLAN, J.B., DALY, C.J. & MCGRATH, J.C. (1994). The innervation and α-adrenoceptor profile of rabbit isolated dorsal cutaneous and subcutaneous resistance arteries. J. Vasc. Res., 31, 30.
23. MCGRATH, J.C. (1982). Evidence for more than one type of postjunctional α-adrenoceptor. Biochem. Pharmacol., 31, 467-484.
24. 2-adrenoceptor-mediated pressor and chronotropic effects in the rat and rabbit. J. Cardiovasc. Pharmacol., 4, S101-S107.
25. MCGRATH, J.C., LEPOR, H. & WYLLIE, M.G. (1996). Report of a unique meeting between the alpha-blocker subcommittee and the pharmaceutical industry. Urology, 48, 665-667.
26. 3H-prazosin binding. Mol. Pharmacol., 29, 321-330.
27. MULVANY, M.J. & HALPERN, W. (1977). Contractile properties of small arterial resistance vessels in spontaneously hypertensive rats. Circ. Res., 41, 19-26.
28. 1-adrenoceptors involved in noradrenaline-induced contractions of rat thoracic aorta and dog carotid artery. Japan. J. Pharmacol., 57, 535-544.
29. 1-adrenoceptor subtypes involved in noradrenaline contraction of the rabbit thoracic aorta. Br. J. Pharmacol., 101, 662-666.
30. 1-adrenoceptors. Pharmacol. Commun., 6, 23-28.
31. 1-adrenoceptors in vascular smooth muscle. Br. J. Pharmacol., 99, 197-201.
32. 2-adrenoceptors. Br. J. Pharmacol., 99, 31-34.
33. 1-adrenoceptor subtypes in rabbit liver: a binding study. Br. J. Pharmacol., 116, 2591-2596.
34. O'ROURKE, M., KEARNS, S. & DOCHERTY, J.R. (1995). Investigation of the actions of chloroethylclonidine in rat aorta. Br. J. Pharmacol, 115, 1399-1406.
35. 2-adrenoceptors. Br. J. Pharmacol., 106, 568-573.
36. 1D-adrenoceptor to the contraction of vascular smooth muscle. J. Pharmacol. Exp. Ther., 275, 1583-1589.
37. RUFFOLO, R.R. (1985). Relative agonist potency as a means of differentiating alpha-adrenoceptors and alpha-adrenergic mechanisms. Clin. Sci., 10, 9s-14s.
38. 1-adrenoceptor subtypes: selective antagonists suggest the existence of a fourth subtype. Eur. J. Pharmacol., 227, 433-436.
39. 1-adrenoceptor subtypes in rabbit cutaneous resistance arteries. Br. J. Pharmacol., 119, 92P.
40. 1-adrenoceptor subtypes in rat mesenteric resistance arteries. Br. J. Pharmacol., 119, 340P.
41. 2-purinoceptors. J. Vasc. Res., 29, 347-352.
42. 1-adrenoceptor antagonists in rat aorta. Br. J. Pharmacol., 118, 299-310.
43. 1-adrenoceptor antagonists on noradrenaline-mediated contraction of rat small mesenteric artery. Br. J. Pharmacol., 118, 1308-1316.
44. 1-adrenoceptors mediating vasoconstriction to noradrenaline and nerve stimulation in the isolated perfused mesentery. Br. J. Pharmacol., 114, 531-536.